h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UMGi014-B
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UMGi014-B
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UMGi014-B (RRID:CVCL_A4JI)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
1st March 2022
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
University Medical Center Goettingen (UMG)
External Databases
Cellosaurus
CVCL_A4JI
,
CVCL_A4JK
,
CVCL_A4JJ
Wikidata
Q105511387
,
Q105511390
,
Q105511392
General Information
Publications
El-Battrawy I et al. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Journal of the American Heart Association. 2018 Mar 24;7(7).
El-Battrawy I et al. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018 Jun 1;20(FI1):f46-f56.
El-Battrawy I et al. Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Frontiers in cell and developmental biology. 2019;7:261.
Khadjeh S et al. CRISPLD1: a novel conserved target in the transition to human heart failure. Basic research in cardiology. 2020 Mar 7;115(3):27.
Huang M et al. Dopamine D1/D5 Receptor Signaling Is Involved in Arrhythmogenesis in the Setting of Takotsubo Cardiomyopathy. Frontiers in cardiovascular medicine. 2021;8:777463.
Sattler K et al. TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes. Scientific reports. 2021 Jul 19;11(1):14689.
Zhong R et al. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. International journal of molecular sciences. 2022 Jul 27;23(15).
Fan X et al. Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells. International journal of molecular sciences. 2022 Jul 31;23(15).
Li Y et al. Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytes. Clinical and translational medicine. 2023 Mar;13(3):e1130.
Subclones
UMGi014-B-1
UMGi014-B-2
UMGi014-B-3
UMGi014-B-4
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.